Gentry Private Wealth’s First Trust Health Care AlphaDEX Fund FXH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$480K Sell
3,925
-178
-4% -$20.4K 0.25% 51
2026
Q1
$450K Sell
4,103
-280
-6% -$31.8K 0.27% 56
2025
Q4
$499K Hold
4,383
0.31% 47
2025
Q3
$481K Hold
4,383
0.33% 54
2025
Q2
$454K Hold
4,383
0.35% 56
2025
Q1
$454K Buy
+4,383
New +$469K 0.37% 59
2024
Q4
Sell
-4,383
Closed -$490K 52
2024
Q3
$490K Hold
4,383
0.4% 41
2024
Q2
$458K Buy
+4,383
New +$460K 0.4% 35

Other funds holding FXH

Gentry Private Wealth's FXH Position: Q2 2026 in Review

Gentry Private Wealth reduced its First Trust Health Care AlphaDEX Fund (FXH) stake by 4.3% in Q2 2026, selling an estimated $20.4K and leaving 3,925 shares worth $480K. The position accounts for 0.25% of the portfolio, ranked #51.

Gentry Private Wealth first reported a position in FXH in Q2 2024 and has held it in 8 quarters since. The position peaked at $499K in Q4 2025. 252 funds tracked by Wall St. Rank hold FXH as of Q2 2026.

  • Gentry Private Wealth held 3,925 shares of First Trust Health Care AlphaDEX Fund worth $480K as of Q2 2026.
  • Gentry Private Wealth sold 178 First Trust Health Care AlphaDEX Fund shares in Q2 2026, an estimated $20.4K.
  • First Trust Health Care AlphaDEX Fund made up 0.25% of Gentry Private Wealth's portfolio in Q2 2026, its #51 holding.
  • Gentry Private Wealth first reported a position in First Trust Health Care AlphaDEX Fund in Q2 2024 and has held it in 8 quarters since.
  • Gentry Private Wealth's First Trust Health Care AlphaDEX Fund position peaked at $499K in Q4 2025.
  • 252 funds tracked by Wall St. Rank held First Trust Health Care AlphaDEX Fund as of Q2 2026.

Based on Gentry Private Wealth's 13F filing for Q2 2026, filed 5 Aug 2026.